格隆汇8月6日丨伊之密(300415.SZ)于投资者互动平台表示，公司的超大型压铸机的客户包括一汽、长 安等。其他相关信息，请关注公司后续的官方信息。 ...

央广网合肥8月1日消息（记者张琳琳 实习记者李甜甜）栽下梧桐树，引得凤凰来。企业的成长壮大，离不开优质 的营商环境。近年来，肥西经开区聚焦企业全生命周期需求，以精准服务破解发展难题，以暖心政策厚植创新沃 土，让企业扎根更安心、发展更顺心。 要素保障"零时差" 精准对接破解难题 在合肥欣竹生物科技有限公司的CIP工序，一排不锈钢清洗罐正在运转，实现对药剂设备内部的清洁。这个总投 资56亿元的生物医药项目，从建设到投产涉及诸多配套需求。 项目落地"加速度" 全流程代办省心省力 "正式电接入原本是个难题，没想到肥西开发区直接带着供电局上门解决。"合肥欣竹项目负责人夏开国说，全方 位的要素保障推动项目加速建设，目前项目1吨多肽原液生产线已经投入使用，共计2款生物类似药已经完成技术 转移并落地欣竹工厂。其中，1款生物类似药进入了临床申报阶段，另1款生物类似药已经获批进入临床阶段，10 吨原液生产线预计明年1季度建成投入使用。 7月29日，在安徽力劲集团压铸机厂房建设现场，工人们正紧张有序地进行高空作业，银白色钢结构厂房已初具规 模。作为新能源汽车产业链的关键一环，该企业的一体化压铸技术将大幅提升整车制造效率。 近年来， ...

Group 1: Company Performance and Strategy - The company held an earnings briefing for the fiscal year 2024 and the first quarter of 2025 on May 20, 2025, to communicate with investors and address their concerns [1][2] - In 2024, the company achieved a revenue of approximately 1.15 billion yuan, representing a year-on-year growth of 14.59%, while the net profit attributable to shareholders decreased by 4.23% to approximately 82.21 million yuan [6][7] - The company has developed a five-year strategic plan (2024-2028) focusing on high-quality development, sustainable growth, and globalization, aiming to become a leader in the global new energy molding equipment and technology sector [3][4] Group 2: Market Outlook and Industry Trends - The global injection molding machine market is projected to grow from approximately 11.41 billion USD in 2024 to 15.86 billion USD by 2030, with a compound annual growth rate (CAGR) of 5.63% [3] - The company anticipates significant growth in exports, with a forecasted export value of 2.1 billion USD in 2024, reflecting a year-on-year increase of 21% [3] - The company is focusing on various downstream application sectors, including mobile transportation, smart home, packaging, and medical devices, to capture emerging opportunities [3] Group 3: Operational Developments - The company has successfully completed its large-scale integrated smart manufacturing base project, which includes the production of 29 die-casting machines and 5,000 high-end injection molding equipment [5] - The company has established a global marketing network with subsidiaries in six countries and 75 domestic and international distributors, covering 38 countries [5] - The company reported a significant increase in foreign sales revenue, amounting to approximately 515 million yuan in 2024, a year-on-year growth of 19.94% [5] Group 4: Financial Management and Challenges - The company has maintained a stable cash dividend policy, with a total cash dividend of 132 million yuan over the past three years, representing a payout ratio of 175.22% [5] - The gross profit margin for 2024 was reported at 29.79%, a decrease of 2.18 percentage points from the previous year, primarily due to rising raw material and labor costs [6] - The company is actively addressing the challenges posed by increased costs and has implemented measures to improve efficiency and reduce expenses [6][7]

Group 1: Industry Overview - In Q1 2025, the demand for injection molding machines remained stable, with a slight year-on-year increase in domestic exports, driven by national policies promoting equipment upgrades in the industrial sector [1] - The company’s injection molding product sales revenue increased year-on-year, outperforming the overall industry level, supported by rapid growth in overseas export business [1] - The automotive industry is the largest downstream sector, benefiting from the development of new energy vehicles and lightweight trends [4] Group 2: Production Capacity and Supply Chain - The company has multiple production facilities in China, including a headquarters and factories in Guangdong, with a total area of over 80,000 square meters dedicated to die-casting and injection molding machines [2] - The company is expanding its production base in Zhejiang, covering approximately 110,000 square meters, to better serve the surrounding industrial cluster [2] - A dedicated supply chain management center has been established to enhance supply chain capabilities and meet the growing procurement scale [2] Group 3: Research and Development - In 2024, the company’s R&D expenditure was 24,586.21 million yuan, a year-on-year increase of 15.78%, accounting for 4.86% of total revenue [6] - The R&D funds are primarily allocated to key projects such as the NEXT2 die-casting machine and A6 high-end intelligent injection molding machine [6] - The company emphasizes innovation-driven high-quality development, with a steadily growing R&D team and capabilities [5][7] Group 4: Competitive Advantages - The company has consistently outpaced industry growth in injection molding machine market share due to a stable and capable team, strong R&D focus, and a comprehensive service system [5] - Direct sales model and high customer satisfaction contribute to the company’s competitive edge [5] - The company’s overseas market presence has expanded, with significant growth in export sales [5] Group 5: Future Outlook - The company aims to continue driving technological and product upgrades, with a vision to become a world-class enterprise in the forming equipment sector by 2025 [8] - The company has reported a solid foundation for continued revenue and profit growth in Q1 2025, setting the stage for a strong performance throughout the year [8]